v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   72,817,887        
Beginning balance at Dec. 31, 2022 $ 145,700 $ 7 $ 561,390 $ (7,246) $ (408,451)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,829)       (36,829)  
Issuance of common stock to directors (in shares)   6,713        
Vesting of restricted stock units (in shares)   111,296        
Vesting of restricted stock units (2,959)   (2,959)      
Exercise of stock options (in shares)   19,483        
Exercise of stock options 131   131      
Stock-based compensation expense 11,056   11,056      
Other comprehensive income (loss) (700)     (700)    
Ending balance (in shares) at Mar. 31, 2023   72,955,379        
Ending balance at Mar. 31, 2023 116,399 $ 7 569,618 (7,946) (445,280)  
Beginning balance (in shares) at Dec. 31, 2022   72,817,887        
Beginning balance at Dec. 31, 2022 145,700 $ 7 561,390 (7,246) (408,451)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (101,435)          
Ending balance (in shares) at Sep. 30, 2023   73,224,030        
Ending balance at Sep. 30, 2023 68,101 $ 7 588,029 (10,049) (509,886)  
Beginning balance (in shares) at Mar. 31, 2023   72,955,379        
Beginning balance at Mar. 31, 2023 116,399 $ 7 569,618 (7,946) (445,280)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (42,355)       (42,355)  
Issuance of common stock to directors (in shares)   4,928        
Vesting of restricted stock units (in shares)   99,836        
Vesting of restricted stock units (1,816)   (1,816)      
Exercise of stock options (in shares)   53,190        
Exercise of stock options 428   428      
Stock-based compensation expense 11,148   11,148      
Other comprehensive income (loss) (3,172)     (3,172)    
Ending balance (in shares) at Jun. 30, 2023   73,113,333        
Ending balance at Jun. 30, 2023 80,632 $ 7 579,378 (11,118) (487,635)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (22,251)       (22,251)  
Issuance of common stock to directors (in shares)   3,936        
Vesting of restricted stock units (in shares)   92,722        
Vesting of restricted stock units (2,465)   (2,465)      
Exercise of stock options (in shares)   14,039        
Exercise of stock options 105   105      
Stock-based compensation expense 11,011   11,011      
Other comprehensive income (loss) 1,069     1,069    
Ending balance (in shares) at Sep. 30, 2023   73,224,030        
Ending balance at Sep. 30, 2023 68,101 $ 7 588,029 (10,049) (509,886)  
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 52,341 $ 7 595,781 (23,555) (519,892) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,923)       (32,923)  
Issuance of common stock to directors (in shares)   4,974        
Vesting of restricted stock units (in shares)   141,563        
Vesting of restricted stock units (2,862)   (2,862)      
Exercise of stock options (in shares)   43,460        
Exercise of stock options 345   345      
Repurchase of common stock (in shares)   (1,320,531)        
Repurchase of common stock (50,019)         (50,019)
Stock-based compensation expense 10,606   10,606      
Other comprehensive income (loss) 12,847     12,847    
Ending balance (in shares) at Mar. 31, 2024   72,236,232        
Ending balance at Mar. 31, 2024 (9,665) $ 7 603,870 (10,708) (552,815) (50,019)
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 52,341 $ 7 595,781 (23,555) (519,892) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (78,615)          
Ending balance (in shares) at Sep. 30, 2024 72,400,000 72,429,625        
Ending balance at Sep. 30, 2024 $ (49,801) $ 7 614,204 (22,809) (598,507) (42,696)
Beginning balance (in shares) at Mar. 31, 2024   72,236,232        
Beginning balance at Mar. 31, 2024 (9,665) $ 7 603,870 (10,708) (552,815) (50,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (43,592)       (43,592)  
Issuance of common stock to directors (in shares)   4,692        
Issuance of common stock to directors 0   (178)     178
Vesting of restricted stock units (in shares)   77,116        
Vesting of restricted stock units (1,360)   (4,279)     2,919
Exercise of stock options (in shares)   25,037        
Exercise of stock options 163   (785)     948
Stock-based compensation expense 9,900   9,900      
Other comprehensive income (loss) (1,104)     (1,104)    
Ending balance (in shares) at Jun. 30, 2024   72,343,077        
Ending balance at Jun. 30, 2024 (45,658) $ 7 608,528 (11,812) (596,407) (45,974)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2,100)       (2,100)  
Issuance of common stock to directors (in shares)   5,060        
Issuance of common stock to directors 0   (192)     192
Vesting of restricted stock units (in shares)   69,362        
Vesting of restricted stock units (662)   (3,289)     2,627
Exercise of stock options (in shares)   12,126        
Exercise of stock options 111   (348)     459
Stock-based compensation expense 9,505   9,505      
Other comprehensive income (loss) $ (10,997)     (10,997)    
Ending balance (in shares) at Sep. 30, 2024 72,400,000 72,429,625        
Ending balance at Sep. 30, 2024 $ (49,801) $ 7 $ 614,204 $ (22,809) $ (598,507) $ (42,696)